X0202 SCHEDULE 13G/A 0002103411 XXXXXXXX LIVE 1 Common Stock, par value $0.00001 per share 02/09/2026 0001800315 Damora Therapeutics, Inc. 36322Q206 221 Crescent Street Building 23, Suite 105 Waltham MA 02453 Rule 13d-1(c) Paramora Holding LLC DE 2045473 0.00 2045473 0.00 2045473 N 3.39 CO Row 11 is based on 60,303,212 shares of Common Stock outstanding as of March 17, 2026 as reported in the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission on March 19, 2026. Damora Therapeutics, Inc. 221 Crescent St., Building 23, Suite 105, Waltham, MA 02453 Paramora Holding LLC 221 Crescent St., Building 23, Suite 105, Waltham, MA 02453 Delaware Y See the response to Item 9 on the attached cover page. See the response to Item 11 on the attached cover page. See the response to Item 5 on the attached cover page. See the response to Item 6 on the attached cover page. See the response to Item 7 on the attached cover page. See the response to Item 8 on the attached cover page. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Paramora Holding LLC /s/ Keri Lantz 04/23/2026